Seegene Inc

Not Available for sale in the United States

  • Real-time
  • CE-IVD

Anyplex™ II
HPV HR Detection

Simultaneous detection of 14 high-risk HPV genotypes in a single reaction

Anyplex™Ⅱ HPV HR Detection simultaneously detects, differentiates and quantifies 14 high-risk HPV genotypes including HPV16 and HPV18 which are implicated as major risk factors for cervical cancer. Based on Seegene’s proprietary DPO™ and TOCE™ technologies, this assay performs on multiplex real-time PCR instrument and enables accurate screening test of HPV infection in a single reaction.



The result represents co-infection that HPV 16 is low (+) in the HEX channel, HPV 18 is intermediate (++) in the Quasar 670 channel.


- hrHPV prevalence and type distribution in rural Zimbabwe: A community-based self-collection study using near-point-of-care GeneXpert HPV testing

- High-Risk human papillomavirus genotype distribution in the Northern region of Portugal: Data from regional cervical cancer screening program

- Self-collected vaginal sampling for the detection of genital human papillomavirus (HPV) using careHPV among Ghanaian women

- Anyplex II HPV28 detection and Anyplex II HPV HR detection assays are highly concordant with other commercial assays for detection of high-risk HPV genotypes in women with high grade cervical abnormalities.

- Clinical validation of Anyplex™ II HPV HR Detection according to the guidelines for HPV test requirements for cervical cancer screening

- Clinical Validation of Anyplex II HPV HR Detection Test for Cervical Cancer Screening in Korea

- Clincal validation of the Anyplex II HPV HR Detection for the Cervical Cancer Screening

- Comparison of the performance of Anyplex II HPV HR, the Cobas 4800 human papillomavirus test and Hybrid Capture 2